By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BTG plc 

10 Fleet Place
Limeburner Lane
London    EC4M 7SB  United Kingdom
Phone: 44-0-20-7575-0000 Fax: 44-0-20-7575-0010



Company News
BTG plc (BTG.L) Snaps Up Tumor Freezing Firm Galil Medical in $110 Million Deal 5/6/2016 5:53:22 AM
BTG plc (BTG.L) To Initiate Multi-Centre TARGET Study Evaluating Dosimetry For 90Y Radioembolisation Therapy In Patients With Hepatocellular Carcinoma 4/4/2016 6:04:06 AM
BTG plc (BTG.L) Announces US Launch Of LC Bead LUMI, Ground-Breaking Radiopaque Embolic Bead 4/1/2016 7:37:36 AM
BTG plc (BTG.L) Release: New Data From Largest Prospective Study On CroFab For Treatment Of Copperhead Snake Envenomation 3/9/2016 11:47:27 AM
BTG plc (BTG.L) Release: First Patient Treated With LC Bead LUMI Radiopaque Embolic Bead Supported By Royal Philips Electronics N.V. (PHG) Live Image Guidance 2/3/2016 6:12:04 AM
BTG plc (BTG.L) Release: First Patients In South Korea Receive TheraSphere Radioembolisation Treatment 1/27/2016 2:21:45 PM
BTG plc (BTG.L) Announces Presentation of New Vistogard (uridine triacetate) Data At ASCO Gastrointestinal Cancers Symposium (ASCO-GI) 1/20/2016 8:14:22 AM
BTG plc (BTG.L) Chief Scours for Next Deals as Lung Device Bet Pays Off 12/18/2015 6:55:19 AM
BTG plc (BTG.L) Announces Positive Data From RENEW Study Of PneumRx Coils 12/14/2015 11:51:23 AM
BTG plc (BTG.L) Announces FDA Approval Of VISTOGARD (Uridine Triacetate) As Antidote To Overdose And Early Onset, Severe, Or Life-Threatening Toxicities From Chemotherapy Drugs 5-Fluorouracil (5-FU) Or Capecitabine 12/14/2015 11:04:31 AM